Acquiring Company
Vertex Pharmaceuticals
Acquired Company
Crinetics Pharmaceuticals
BostonSan DiegoBiotechnologyHealth CareTherapeuticsBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Vertex Pharmaceuticals has announced its plan to acquire Crinetics Pharmaceuticals for $85.00 per share in cash, totaling approximately $10 billion. This acquisition aims to strengthen Vertex's portfolio with Crinetics' innovative therapies for endocrine diseases, particularly in the fields of acromegaly and congenital adrenal hyperplasia. The deal was unanimously approved by both companies' boards and is anticipated to close in Q3 2026.
Quick answer
Vertex Pharmaceuticals is acquiring Crinetics Pharmaceuticals for $10 billion, announced July 6, 2026. Vertex Pharmaceuticals is based in Boston, Massachusetts, United States.
- How much did Vertex Pharmaceuticals pay for Crinetics Pharmaceuticals?
- The reported deal value is $10 billion.
- What does Vertex Pharmaceuticals do?
- Vertex is a global biotechnology company focused on innovative medicines for serious diseases.
- Where are Vertex Pharmaceuticals and Crinetics Pharmaceuticals based?
- Vertex Pharmaceuticals is based in Boston, Massachusetts, United States. Crinetics Pharmaceuticals is based in San Diego, California, United States.
- Who are the decision-makers at Vertex Pharmaceuticals?
- Fundz holds 3 contacts at Vertex Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
- Yarrow Bioscience completes merger with VYNE Therapeutics (July 27, 2026)
Who to call at Vertex Pharmaceuticals, and when
When Vertex Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Vertex Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vertex Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vertex Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vertex Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals was acquired by Vertex Pharmaceuticals, based in Boston. The deal was reported on July 6, 2026. Vertex is a global biotechnology company focused on innovative medicines for serious diseases. Vertex Pharmaceuticals is publicly traded (VRTX) and operates in Biotechnology.
When did Vertex Pharmaceuticals acquire Crinetics Pharmaceuticals?
Vertex Pharmaceuticals's acquisition of Crinetics Pharmaceuticals was reported on July 6, 2026. Vertex Pharmaceuticals has announced its plan to acquire Crinetics Pharmaceuticals for $85.00 per share in cash, totaling approximately $10 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Crinetics Pharmaceuticals do?
Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.